Abstract
Infection with human herpesvirus type 8 and with human T-cell leukaemia virus type-1 shows strong geographic variations. We conducted this study to assess prevalence and risk factors for human herpesvirus type 8 infection in Havana City, Cuba. Information and residual serum samples already collected for a hospital based case–control study were used. A total of 379 individuals (267 males and 112 females; median age=63 years) were evaluated. Antibodies to the lytic antigen of human herpesvirus type 8 were detected by using an immunofluorescence assay, while human T-cell leukaemia virus type-1 serology was performed by means of an ELISA test (alpha Biotech). Overall, 64 subjects (16.9%, 95% confidence interval: 13.1–20.0) were positive for human herpesvirus type 8 antibodies. Human herpesvirus type 8 seroprevalence significantly increased with age (odds ratio=1.9 for ⩾65 vs <55 years), and was twice as frequent in blacks than in whites. No association emerged with gender, socio-economic indicators, family size, history of sexually transmitted disease, sexual behaviour. Overall, 16 persons had anti-human T-cell leukaemia virus type-1 antibodies (4.2%, 95% confidence interval: 2.2–6.4). No relationship emerged between human T-cell leukaemia virus type-1 and human herpesvirus type 8 serostatus. The study findings indicate that human herpesvirus type 8 infection is relatively common in Havana City, Cuba, suggesting that Cuba may represent an intermediate endemical area. Sexual transmission does not seem to play a major role in the spread human herpesvirus type 8 infection.
Similar content being viewed by others
Main
Since its discovery in 1994, the human herpesvirus type 8 (HHV-8) – the causal agent of Kaposi's sarcoma (KS) – has been documented in virtually every form of KS, i.e., in the classic, or Mediterranean type; in the endemic, or African type; and in the AIDS-associated type (Chang et al, 1994; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 1997). Many cross-sectional investigations conducted in different geographic areas have put in evidence that the prevalence of HHV-8 infection mirrors incidence rates of AIDS-unrelated KS. The lack of standardised serological assays against HHV-8 antigens still represents a major drawback for the comparison of findings from different investigations (IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 1997; Schatz et al, 2001).
The prevalence of HHV-8 infection in Caribbean populations has been little investigated, and, in these areas, incidence rates for KS are not available (Lennette et al, 1996; Chatlynne and Ablashi, 1999). About 8% of male blood donors, aged 50 years or older, were seropositive for HHV-8 infection in Jamaica (Manns et al, 1998), while an investigation conducted among Haitian women migrated to the United States showed that 29% of them were infected with HHV-8 (Goedert et al, 1997).
To study the distribution of HHV-8 infection, we took advantage of a case–control study on oral cancer conducted in Havana City, Cuba, part of a wider study coordinated by the International Agency for Research on Cancer, Lyon (Garrote et al, 2001). In addition we examined the prevalence of seropositivity for HHV-8 antibodies and certain potential correlates of infection, such as socio-demographic characteristics, history of sexually transmitted diseases (STD) and sexual behaviour, and infection with human T-cell leukaemia virus type-1 (HTLV-1).
Methods
This seroepidemiological investigation took advantage of residual serum samples and from information already collected in a hospital-based case–control study (Garrote et al, 2001). The first 200 patients newly diagnosed with cancer of the oral cavity or of the oropharynx diagnosed between April 1996 and July 1999 in the Instituto Nacional de Oncología y Radiobiología, Havana City, Cuba, represented the cases of the original study. These 200 cases were histologically confirmed and they did not receive any prior local or systemic cancer treatment. During the same period, an equal number of controls were identified from the same hospitals of the cases and they were matched to cases by sex and age (in quinquennia). The controls had no history of, or current suspicion of, cancer of the oral cavity or oropharynx. With respect to eligible reasons of hospital admission for control subjects, diseases associated positively or negatively with the known or suspected risk factors for cancer of the oral cavity or oropharynx (e.g., heavy smoking or alcohol abuse) were excluded. Cases and controls consented to participate voluntarily in the study and they were in physical and mental conditions to give reliable answers to the questionnaire (Garrote et al, 2001).
Potential infection with human immunodeficiency virus (HIV) was investigated, though none of the enrolled individuals were aware of having acquired HIV infection. However, neither the cases nor the controls were tested for HIV antibodies.
Residual sera for assessing the presence of antibodies against HHV-8 were not available for nine cases and 12 controls (median age: 62 years) out of the 400 individuals originally enrolled in the case–control study. Thus, 379 individuals (267 males and 112 females; median age=63 years) constituted the study group for the present investigation.
Antibodies to the lytic antigen of HHV-8 were detected by using an immunofluorescence assay (IFA) based on BCBL-1 (body cavity B-cell lymphomas) cell line (obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, National Institutes of Health, from Drs M McGrath and D Ganem) and on BCP-1 cell line. For the purpose of this study, titres of 1 : 20 or more were considered positive. Details on the assay were previously published (Andreoni et al, 1999; Rezza et al, 1999; Schatz et al, 2001). HTLV-1 serology was performed by means of an ELISA test (alpha Biotech). ELISA-positive findings were all confirmed by means of Western blot technique (GeneLab).
Statistical analysis
At univariate analysis, the chi-square test for trend was used to test the statistical significance between ordered categorical variables and HHV-8 seropositivity (Armitage and Berry, 1987). Odds ratios (OR) and their 95% confidence intervals (CI) were used to assess the association between HHV-8 seropositivity and various characteristics and exposures by means of unconditional multiple logistic regression (Breslow and Day, 1980).
Results
Overall, 64 individuals (47 men and 17 women, median age=63 years) (16.9%, 95% CI: 13.1–20.0) were positive for HHV-8 antibodies. Prevalence of HHV-8 infection was similar among the 191 patients with cancer (17.3%) and the 188 controls (16.5%) (P=0.95) (data not shown in tables).
As listed in Table 1, HHV-8 seroprevalence significantly increased with the increase of age (χ2 for trend, P=0.04), ranging from 12.2% in subjects younger than 55 years to 21.1% in those aged 65 years or older (OR=1.9). HHV-8 infection was twice as frequent in blacks than in whites (95% CI: 1.0–4.4), whereas males and females presented similar seropositivity rates (17.6 and 15.2%, respectively) (Table 1).
All associations described below were evaluated after adjustment for age, gender, and ethnic group. None of the socio-economic indicators (e.g., education: ⩽5 years vs ⩾9, OR=1.4, 95% CI: 0.7–3.0), and family size indicators (i.e., ⩾8 siblings vs ⩽3, OR=1.4, 95% CI=0.7–2.9) turned out to be associated with HHV-8 seropositivity (Table 1).
Seropositivity for HHV-8 antibodies was not associated with history of STD, neither with sexual behaviour, such as age at first intercourse or lifetime number of sexual partners (Table 2). These results did not change when the analysis was separately conducted among males or females (data not shown in tables).
Overall, 16 of these 379 examined persons had anti-HTLV-1 antibodies (4.2%, 95% CI: 2.2–6.4). No relationship emerged between HTLV-1 and HHV-8 serostatus, though a non-statistically significant inverse association was recorded (Table 2).
Discussion
The prevalence of HHV-8 infection in this group of population living in Havana City, Cuba, appeared to be intermediate between those reported in areas where KS is rare, like northern Europe and North America, and areas where KS is more common, like southern Italy (Geddes et al, 1995; Parkin et al, 1997). Interestingly, the findings of this seroprevalence investigation suggest that sexual habits, particularly sexual promiscuity, are not among the main determinants of HHV-8 infection in Cuba. The lack of association between HHV-8 and HTLV-1 infections also points to a minor role of the sexual route of transmission for these two viral infections in the general population of Cuba.
Age and ethnic group turned out to be the strongest determinants of HHV-8 infection. An increase in prevalence of HHV-8 infection with ageing has been consistently reported (IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 1997; Plancoulaine et al, 2000). In comparison with population groups of the same age (i.e., with a median age of 63 years), the HHV-8 prevalence recorded in this Cuban population appears to be higher than that observed in Asian countries (IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 1997; Chatlynne and Ablashi, 1999), and similar to that observed among cancer patients aged 50 years or older in the South of Italy (i.e., 16.0%) (Serraino et al, 2000; Vitale et al, 2001).
Black ethnic origin was associated with a two-fold higher risk of being infected with HHV-8 than white origin, whereas mulatto ethnic origin was at intermediate risk (i.e., 1.4-fold). Such observation mirrors findings from studies of other γ-herpesviruses conducted in North America, showing higher prevalence of antibodies against Epstein-Barr virus (EBV) in black, as compared to white Americans (Hallee et al, 1974), though explanations for these findings are still unknown.
No association emerged, in this study, between HHV-8 and demographic indicators, such as occupation and education, suggesting that the spread of HHV-8 in the general population of Havana City, Cuba, is not influenced by socio-economic differences. In this connection the lack of association between HHV-8 seropositivity and family size may be noted. None of the sexual behaviours investigated, and none of the self-reported STD were associated with HHV-8 infection. In accordance to other studies, these findings tend to exclude a major role of sexual transmission of HHV-8 in HIV-negative heterosexual adults (IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 1997).
Sixteen out of the 379 study subjects (4.2%) were positive for HTLV-1 antibodies. Such prevalence was slightly lower than those observed in other Caribbean islands where HTLV-1 antibodies are usually recognised in up to 15% of adults (Blattner et al, 1982; Yoshida, 1999). Low prevalence for, or even lack of infection with HTLV-I was found in other studies conducted on blood donors in Cuba, some of which did not apparently discriminate between HTLV-1 and HTLV-II (Hernandez Ramirez et al, 1991; Silva Cabrera et al, 1997). However, the report of sporadic cases of HTLV-1-associated with tropical spastic paraparesis suggests that both the spread of HTLV-1 and major route of transmission in Cuba need to be better investigated (Estrada et al, 1995). The lack of association found in this investigation between HHV-8 and HTLV-1 infections suggests that these viruses do not share similar transmission modalities. This fact is little surprising since, in endemic areas, HTLV-1 is mainly transmitted from mother to child by breast feeding, or through infection via contaminated blood (IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 1996).
In conclusion, the overall findings show that HHV-8 infection is relatively common among older adults living in Havana City, Cuba, suggesting that Cuba represents an intermediate endemical area. HHV-8 and HTLV-1 infections are likely to spread with different routes, and sexual transmission does not seem to play a major role in the spread of HHV-8 infection in Cuba.
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Andreoni M, El-Sawaf G, Rezza G, Ensoli B, Nicastri E, Ventura L, Ercoli L, Sarmati L, Rocchi G (1999) High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: evidence of non sexual transmission. JNCI 91: 465–469
Armitage P, Berry G (1987) Statistical methods in medical research Oxford: Blackwell Scientific publications
Blattner W, Kalyanaraman VS, Robert-Guroff M, Lister TA, Galton DA, Sarin PS, Crawford MH, Catovsky D, Greaves M, Gallo RC (1982) The human type C retrovirus, HTLV in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma. Int J Cancer 30: 257–264
Breslow NE, Day NE (1980) Statistical methods in cancer research – Volume 1 The analysis of case-control studies. IARC Scientific Publications No. 32 Lyon: IARC
Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865–1869
Chatlynne LG, Ablashi DV (1999) Seroepidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV). Sem Cancer Biol 9: 175–185
Estrada RA, Luis S, Mustelier R, Ruiz W, Rodriguez B, Miranda A, Roman GC (1995) Absence of human retroviral antibodies in epidemic neuropathy in Cuba: report of the first two cases of HTLV-I-associated tropical spastic paraparesis observed in Cuba. J Neurol Sci 128: 112–113
Garrote LF, Herrero R, Reyes RM, Vaccarella S, Anta JL, Ferbeye L, Munoz N, Franceschi S (2001) Risk factors for cancer of the oral cavity and oro-pharynx in Cuba. Br J Cancer 85 (1): 46–54
Geddes M, Franceschi S, Balzi D, Arniani S, Gafa L, Zanetti R (1995) Birthplace and classic Kaposi's sarcoma in Italy. Associazione Italiana Registri Tumori. J Natl Cancer Inst 87: 1015–1017
Goedert JJ, Kedes DH, Ganem D (1997) Antibodies to human herpesvirus 8 in women and infants born in Haiti and the USA. Lancet 349: 1368
Hallee TJ, Evans AS, Niederman JC, Brooks CM, Voegtly JH (1974) Infectious mononucleosis at the U.S. Military Academy: a prospective study of a single class over four years. Yale J Biol 47: 182–195
Hernandez Ramirez P, Rivero Jimenez R, Ballester Santovenia M, Navea Leyva L, Matutes E, Catovsky D, Yamaguchi K, Fukuyoshi Y, Nishimura Y, Kiyokawa T (1991) Very low seroprevalence of HTLV-I/II in Cuba: antibodies in blood donors and in hematological and nonhematological patients. Vox Sang 61: 277–278
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1996) Human immunodeficiency viruses and human t-cell lymphotropic viruses. Lyon, June 11–18, 1996. IARC Monogr Eval Carcinog Risks Hum 67: 271–273
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1997) Epstein-Barr virus and Kaposi's sarcoma herpesvirus/human herpesvirus 8. Lyon, June 17–24, 1997. IARC Monogr Eval Carcinog Risks Hum 70: 375–463
Lennette ET, Blackbourn DJ, Levy JA (1996) Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 348: 858–861
Manns A, Strickler HD, Hanchard B, Manassaram DM, Waters D, Ablashi DV (1998) Age- and sex-specific seroprevalence of human herpesvirus 8 in Jamaica. J Natl Cancer Inst 90: 1102–1103
Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (1997) Cancer incidence in five continents – Volume VII International Agency for Research on Cancer Sci Publ no. 143 Lyon: IARC
Plancoulaine S, Abel L, van Beveren M, Tregouet DA, Joubert M, Tortevoye P, de The G, Gessain A (2000) Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet 356: 1062–1065
Rezza G, Andreoni M, Dorrucci M, Pezzotti P, Monini P, Zerboni R, Salassa B, Colangeli V, Sarmati L, Nicastri E, Barbanera M, Pristera R, Aiuti F, Ortona L, Ensoli B (1999) Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. JNCI 91: 1468–1474
Schatz O, Monini P, Bugarini R, Neipel F, Schulz TF, Andreoni M, Erb P, Eggers M, Haas J, Butto S, Lukwiya M, Bogner JR, Yaguboglu S, Sheldon J, Sarmati L, Goebel FD, Hintermaier R, Enders G, Regamey N, Wernli M, Sturzl M, Rezza G, Ensoli B (2001) Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays. J Med Virol 65: 123–132
Serraino D, Bordonaro R, Failla G, De Paoli P, Colina P, Tedeschi RM, Ippolito G (2000) Prevalence of HHV-8 infection among cancer patients in Sicily. Int J Cancer 86: 448–449
Silva Cabrera E, Perez Guevara MT, Lubian Caballero AL, de la Fuente Arzda JL, Navea Leyva L, Cruz Sui O (1997) Search for antibodies against human T-cell lymphotropic virus type I (HTLV-I) in blood donors and risk groups. Rev Cubana Med Trop 49: 24–27
Vitale F, Briffa DV, Whitby D, Maida I, Grochowska A, Levin A, Romano N, Goedert JJ (2001) Kaposi's sarcoma herpes virus and Kaposi's sarcoma in the elderly population of 3 Mediterranean islands. Int J Cancer 91: 588–591
Yoshida M (1999) Human C-type oncoviruses and T-cell leukemia/lymphoma. InMicrobes and Malignancy, Parsonnet J (ed) pp289–307, NY: Oxford University Press
Acknowledgements
This study was supported by Progetto Nazionale AIDS, grant No. 20C.15.
We thank Michela Di Pasquale for assistance in text editing.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Fernandez, L., Serraino, D., Rezza, G. et al. Infection with human herpesvirus type 8 and human T-cell leukaemia virus type 1 among individuals participating in a case–control study in Havana City, Cuba. Br J Cancer 87, 1253–1256 (2002). https://doi.org/10.1038/sj.bjc.6600613
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6600613
- Springer Nature Limited